Viral Vector Production (Research-Use) Market Future Trends Influencing Growth Through 2030
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Value Of The Viral Vector Production (Research-Use) Market Progress Between 2026 And 2030?
The viral vector production (research-use) market size has witnessed swift expansion in recent years. It is projected to increase from $1.77 billion in 2025 to $2.04 billion in 2026, reflecting a compound annual growth rate (CAGR) of 15.2%. This historical growth can be ascribed to heightened investment in gene therapy research, the broadening of academic and translational research programs, the presence of advanced cell culture technologies, the increasing application of viral vectors in oncology studies, and the expansion of contract research activities.
The viral vector production (research-use) market size is projected for significant expansion over the coming years, with an anticipated growth to $3.56 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.9%. This projected growth can be attributed to several factors, including an increasing demand for next-generation gene delivery tools, the rising adoption of automation in research laboratories, the expansion of CRISPR and gene editing research, growing collaboration between academia and biopharma, and an increasing focus on reproducibility and standardization. Prominent trends within the forecast period encompass the increasing adoption of scalable viral vector manufacturing platforms, a rising demand for high-purity research-grade vectors, the growing use of suspension cell culture systems, the expansion of automated upstream and downstream processing, and an enhanced focus on vector characterization and quality control.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28350&type=smp
Which Drivers Are Supporting The Viral Vector Production (Research-Use) Market Growth?
The escalating occurrence of genetic disorders is projected to fuel the expansion of the viral vector production (research-use) market moving forward. Genetic disorders are health conditions or diseases stemming from irregularities in an individual’s deoxyribonucleic acid, which can be inherited from one or both parents or arise from new genetic mutations. The increase in genetic disorders is attributable to rising parental age, which enhances the probability of genetic mutations being passed on to offspring. The increasing prevalence of genetic disorders underpins the growth of viral vector production (research-use) by stimulating demand for advanced gene delivery tools necessary for studying disease mechanisms and developing potential therapeutic approaches. For instance, in November 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based government public health agency, Trisomy 21 (Down syndrome) occurs in about 1 in 643 births, resulting in approximately 5,713 new cases annually, and Trisomy 18 occurs in about 1 in 3,336 births, or roughly 1,101 cases yearly. Therefore, the rising occurrence of genetic disorders is expected to propel the growth of the viral vector production (research-use) market.
What Are The Main Segments Within The Viral Vector Production (Research-Use) Market Segment Structure?
The viral vector production (research-use) market covered in this report is segmented –
1) By Type: Adeno-Associated Virus (AAV), Lentivirus, Adenovirus, Retrovirus, Other Types
2) By Production: Transient Transfection, Stable Cell Line, Viral Packaging System, Other Production Methods
3) By Workflow: Upstream Processing, Downstream Processing
4) By Application: Gene Therapy, Vaccines, Oncology, Infectious Diseases, Other Applications
5) By End-Use: Pharmaceutical And Biopharmaceutical Companies, Research Institutes
Subsegments:
1) By Adeno-Associated Virus: Single-Stranded Adeno-Associated Virus, Self-Complementary Adeno-Associated Virus, Hybrid Adeno-Associated Virus
2) By Lentivirus: Human Immunodeficiency Virus-Based Lentivirus, Feline Immunodeficiency Virus-Based Lentivirus, Equine Infectious Anemia Virus-Based Lentivirus
3) By Adenovirus: Replication-Competent Adenovirus, Replication-Deficient Adenovirus, Helper-Dependent Adenovirus
4) By Retrovirus: Gamma Retrovirus, Spumavirus (Foamy Virus), Alpha Retrovirus
5) By Other Types: Herpes Simplex Virus Vectors, Baculovirus Vectors, Sendai Virus Vectors
What Trends Are Influencing The Evolution Of The Viral Vector Production (Research-Use) Market?
Leading companies in the viral vector production market are concentrating on developing advanced solutions, such as specialized cell culture media, to enhance transfection efficacy, increase viral vector output, and guarantee consistent quality for research uses. Cell culture media are nutrient-rich liquids crafted to support the proliferation and upkeep of cells outside their natural environment. They comprise essential elements like amino acids, vitamins, and growth factors, optimized for particular cell types and applications. For instance, in January 2023, FUJIFILM Irvine Scientific, a US-based life sciences firm, unveiled BalanCD HEK293 Viral Feed, which is the world’s initial chemically defined nutrient feed specifically tailored for HEK293 suspension cultures utilized in AAV viral vector manufacturing. Through this launch, the company aims to significantly elevate adeno-associated virus (AAV) yields, showing up to 67% improvement in viral packaging efficiency when compared to basal media. This feed is engineered for scalable gene therapy and biotech workflows, providing reliable performance across formats and compatibility with multiple media systems.
Who Are The Companies Participating In The Viral Vector Production (Research-Use) Market?
Major companies operating in the viral vector production (research-use) market are Sanofi S.A., Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company, Lonza Group AG, Sartorius AG, Charles River Laboratories International Inc., FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Curia Inc., AGC Biologics GmbH, SK pharmteco Inc., Oxford Biomedica Plc, Waisman Biomanufacturing, Voyager Therapeutics Inc., FinVector Oy, Batavia Biosciences BV., GENEZEN LABORATORIES, BioNTech IMFS GmbH, VGXI Inc., Tonix Pharmaceuticals, Cell and Gene Therapy Catapult, Mustang Bio Inc.
Get The Full Viral Vector Production (Research-Use) Market Report:
Which Region Has The Greatest Market Share In The Viral Vector Production (Research-Use) Market?
North America was the largest region in the virtual vector production (research-use) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral vector production (research-use) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Viral Vector Production (Research-Use) Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Viral Vector Production (Research-Use) Market 2026, By The Business Research Company
Viral Vector Manufacturing Market Report 2026
https://www.thebusinessresearchcompany.com/report/viral-vector-manufacturing-global-market-report
Viral And Non Viral Vector Manufacturing Market Report 2026
Oral Expectorant Market Report 2026
https://www.thebusinessresearchcompany.com/report/oral-expectorant-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
